MAJOR TRANSACTION IN RELATION TO DISPOSAL OF AN
INDIRECT NON-WHOLLY OWNED SUBSIDIARY
Kontafarma China Holdings Limited (01312)
  • Equity Transfer Agreement
    		•
  • Property Valuation Reports
    		•
  • Asset Valuation Report
    		•
  • Letter from BDO Limited
    		•
  • Letter from the Board on profit forecast
    		•
  • Written consent of BDO Limited
    		•
  • Written consent of Beijing Zhongtianhua Asset Appraisal Co., Ltd.
    		•
  • Written consent of Valplus Consulting Limited
    		•